J. Sierra-Madero

发表

Cross-Sectional Analysis of Late HAART Initiation in Latin America and the Caribbean: Late Testers and Late Presenters

D. Masys, P. Cahn, C. César, 2011, PloS one.

A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts

R. Hogg, K. Buchacz, T. Sterling, 2016, Journal of the International AIDS Society.

J. Calva, V. Ramírez-Amador, G. Anaya-Saavedra, 2006, Archives of medical research.

Myocardial Inflammatory Changes Before and After Antiretroviral Therapy Initiation in People With Advanced Human Immunodeficiency Virus Disease

S. Perez-Patrigeon, B. Crabtree-Ramírez, J. Sierra-Madero, 2020, Open forum infectious diseases.

Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART.

G. Ruiz-Palacios, J. Santos, J. Sierra-Madero, 2009, Vaccine.

A Randomized, Controlled Study on the Safety and Efficacy of Maraviroc and/or Favipiravir vs Currently Used Therapy in Severe COVID-19 Adults. “COMVIVIR” Trial.

S. Ávila-Ríos, G. Reyes-Terán, S. Mummidi, 2020 .

Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial.

M. Lederman, L. Montaner, S. Ellenberg, 2014, The lancet. HIV.

Efficacy and Safety of Maraviroc Versus Efavirenz, Both With Zidovudine/Lamivudine: 96-Week Results From the MERIT Study

M. Saag, I. Frank, R. Wood, 2010, HIV clinical trials.

Antiretroviral therapy in HIV‐1‐infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation

L. Montaner, L. Azzoni, I. Sanne, 2016, Journal of leukocyte biology.

Lingual ulcer as the only sign of recurrent mycobacterial infection in an HIV/AIDS-infected patient.

V. Ramírez-Amador, G. Anaya-Saavedra, J. Sierra-Madero, 2005, Medicina oral, patologia oral y cirugia bucal.

HIV Drug Therapy in the Americas 16–18 April 2015, Mexico City, Mexico

M. Lederman, D. Podzamczer, D. Kuritzkes, 2015, Journal of the International AIDS Society.

Functional Outcomes 18 Months After Total and Midarm Transplantation: A Case Report.

M. Vilatoba, F. Gómez-Pérez, J. Sierra-Madero, 2018, Transplantation proceedings.

Association Between Frailty and HIV-Associated Neurodegenerative Disorders Among Older Adults Living with HIV.

H. Amièva, B. Crabtree-Ramírez, J. Sierra-Madero, 2018, AIDS research and human retroviruses.

High prevalent human papillomavirus infections of the oral cavity of asymptomatic HIV-positive men

A. García-Carrancá, B. Crabtree-Ramírez, Y. Caro-Vega, 2020, BMC Infectious Diseases.

Effects of thalidomide on HIV‐associated wasting syndrome: a randomized, double‐blind, placebo‐controlled clinical trial

G. Reyes-Terán, G. Ruiz-Palacios, J. Calva, 1996, AIDS.

Prevalence and variables associated with an abnormal ankle-brachial index among patients with human immunodeficiency virus/acquired immunodeficiency syndrome

J. E. Anaya-Ayala, C. Hinojosa, H. Laparra-Escareno, 2018, Vascular.

Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America

V. Fink, B. Grinsztejn, B. Shepherd, 2016, PloS one.

Oral manifestations of HIV infection by gender and transmission category in Mexico City.

V. Ramírez-Amador, J. Sierra-Madero, L. Esquivel‐Pedraza, 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS Study.

M. Lederman, L. Montaner, S. Ellenberg, 2014, The lancet. HIV.

Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men

A. García-Carrancá, B. Crabtree-Ramírez, Y. Caro-Vega, 2014, BMC Infectious Diseases.

Pilot, Randomized Study Assessing Safety, Tolerability and Efficacy of Simplified LPV/r Maintenance Therapy in HIV Patients on the 1st PI-Based Regimen

J. Montaner, J. Sampalis, P. Cahn, 2011, PloS one.

A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy

P. Cahn, J. Pape, E. Gotuzzo, 2017, PloS one.

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy

W. Wester, T. Sterling, P. Cahn, 2022, BMC Infectious Diseases.

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

Daniel F. Martin, S. Walmsley, C. Robinson, 2002, The New England journal of medicine.

[Active tuberculosis in a cohort of HIV-infected inmates in a prison in Mexico City: clinical and epidemiological characteristics].

S. Bautista-Arredondo, J. Sifuentes-Osornio, B. Crabtree-Ramírez, 2012, Salud publica de Mexico.

The maraviroc expanded access program — safety and efficacy data from an open-label study

A. Lazzarin, J. Molina, C. Craig, 2015, HIV clinical trials.

Transfusion-Associated HIV Infection in Mexico Related to Paid Blood Donors; HIV Epidemic

A. Mohar, G. Ruiz-Palacios, N. Mueller, 2004 .

Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years

J. Singer, J. Montaner, Zunyou Wu, 2014, Journal of the International AIDS Society.

Activity of ticarcillin/clavulanate and piperacillin/tazobactam (YTR 830; CL-298,741) against clinical isolates and against mutants derepressed for class I beta-lactamase.

J. Washington, J. Sierra-Madero, C. Knapp, 1989, Diagnostic microbiology and infectious disease.

Risk factors associated with HCV co-infection amongst MSM and transgender women living with HIV in Mexico City: a case-control study.

J. Sierra-Madero, J. F. Sánchez-Ávila, A. Camiro-Zúñiga, 2022, Annals of hepatology.

Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients

M. Lederman, R. Dersimonian, B. Andrade, 2017, Journal of virus eradication.

Role of beta-lactamase and different testing conditions in oxacillin-borderline-susceptible staphylococci

J. Washington, J. Sierra-Madero, C. Knapp, 1988, Antimicrobial Agents and Chemotherapy.

Molecular cloning of a Salmonella typhi LT‐like enterotoxin gene

G. Ruiz-Palacios, Y. López-Vidal, E. Calva, 1988, Molecular microbiology.

HIV & Hepatitis in the Americas 28–30 April 2016, Mexico City, Mexico

N. Volkow, K. Tashima, D. Podzamczer, 2016, Journal of the International AIDS Society.

Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model

C. del Rio, M. A. Colchero, S. Bautista-Arredondo, 2015, PloS one.

Clinical outcomes of first-line antiretroviral therapy in Latin America: analysis from the LATINA retrospective cohort study

W. Belloso, Jorge Sanchez, M. Losso, 2016, International journal of STD & AIDS.

Prospective, Randomized, Open Label Trial of Efavirenz vs Lopinavir/Ritonavir in HIV+ Treatment-Naive Subjects With CD4+<200 cell/mm3 in Mexico

J. Montaner, L. Soto-Ramírez, S. Rangel-Frausto, 2010, Journal of acquired immune deficiency syndromes.

A Randomized, Controlled Study on the Safety and Efficacy of Maraviroc and/or Favipiravir Vs Currently Used Therapy in Severe COVID-19 Adults. (COMVIVIR, clinicaltrials.gov NCT04475991)

G. Reyes-Terán, A. Pérez-García, J. Hernández-Ruiz, 2021 .

Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial

D. Manzur-Sandoval, J. C. Crispín, S. Valdés-Ferrer, 2022, Molecular Medicine.

Exceptional T CD4+ recovery post-ART is linked to a lower HIV reservoir with a specific immune differentiation pattern.

L. Soto-Ramírez, S. Perez-Patrigeon, M. Viveros‐rogel, 2021, AIDS research and human retroviruses.

Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial

M. Lederman, L. Azzoni, B. Rodriguez, 2017, Pathogens & immunity.

Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center.

C. Aguilar-Salinas, J. Sifuentes-Osornio, J. Sierra-Madero, 2021, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

THE CHANGING CLINICAL SPECTRUM OF HUMAN IMMUNODEFICIENCY VIRUS (HIV)-RELATED ORAL LESIONS IN 1,000 CONSECUTIVE PATIENTS: A 12-YEAR STUDY IN A REFERRAL CENTER IN MEXICO

V. Ramírez-Amador, G. Anaya-Saavedra, J. Sierra-Madero, 2002, Medicine.

High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.

M. Lizano, A. Mohar, A. García-Carrancá, 2001, Gynecologic oncology.

Late Diagnosis Due to Missed Opportunities and Inadequate Screening Strategies in HIV Infected Mexican Women

J. Sierra-Madero, P. Volkow-Fernández, A. Martin-Onraët, 2017, AIDS and Behavior.

The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead

P. Cahn, O. Sued, A. Pozniak, 2020, Journal of the International AIDS Society.

Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients

M. Addo, S. Perez-Patrigeon, L. Chávez-Galán, 2015, Journal of the International AIDS Society.

High prevalence of late diagnosis of HIV in Mexico during the HAART era.

B. Crabtree-Ramírez, Y. Caro-Vega, J. Sierra-Madero, 2012, Salud publica de Mexico.

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19

J. Granados-Arriola, G. Domínguez-Cherit, A. Zentella-Dehesa, 2021, Aging and disease.

Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin

J. Washington, J. Sierra-Madero, C. Knapp, 1990, Antimicrobial Agents and Chemotherapy.

Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone

J. Washington, J. Sierra-Madero, C. Knapp, 1988, Antimicrobial Agents and Chemotherapy.

Role of 3-Lactamase and Different Testing Conditions in Oxacillin-

J. Sierra-Madero, '. C. Knapp, '. C. Karaffa, 2022 .

Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial.

G. Reyes-Terán, V. Ramírez-Amador, J. Sierra-Madero, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Oral clinical markers and viral load in a prospective cohort of Mexican HIV-infected patients.

L. Soto-Ramírez, V. Ramírez-Amador, G. Anaya-Saavedra, 2001, AIDS.

Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.

Juan Sierra-Madero, V. Ramírez-Amador, G. Anaya-Saavedra, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical Spectrum of Oral Secondary Syphilis in HIV-Infected Patients

V. Ramírez-Amador, G. Anaya-Saavedra, B. Crabtree-Ramírez, 2012, Journal of sexually transmitted diseases.

False-positive results in the galactomannan Platelia™ Aspergillus assay with generic piperacillin/tazobactam.

J. Sierra-Madero, A. Ponce-de-León, E. Ortiz-Brizuela, 2019, Revista iberoamericana de micologia.

Fulminant amebic colitis

A. Gamboa-Domínguez, J. Sierra-Madero, Takeshi Takahashi, 1997, Diseases of the colon and rectum.

Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B.

L. Muñoz-Espinosa, R. Moreno-Alcántar, M. Ramos-Gómez, 2021, Revista de gastroenterologia de Mexico.

Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B.

L. Muñoz-Espinosa, R. Moreno-Alcántar, M. Ramos-Gómez, 2021, Revista de gastroenterologia de Mexico.

Metabolic acidosis and hepatic steatosis in two HIV-infected patients on stavudine (d4T) treatment.

J. Sierra-Madero, P. Cornejo-Juárez, P. Volkow-Fernández, 2003, Archives of medical research.

Changing risk factors for HIV infection.

A. Mohar, J. Pérez-Padilla, J. Sierra-Madero, 2002, Archives of medical research.

Add-on Pyridostigmine Enhances CD4+ T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study

J. Alcocer-Varela, S. Valdés-Ferrer, Carlos A. Rodriguez-Osorio, 2017, Front. Immunol..

Mexican consensus on the diagnosis and management of hepatitis C infection.

R. Vázquez-Frias, N. Méndez-Sánchez, F. Bosques-Padilla, 2015, Annals of hepatology.

Transfusion-associated HIV infection in Mexico related to paid blood donors; HIV epidemic.

A. Mohar, G. Ruiz-Palacios, N. Mueller, 2004, International journal of STD & AIDS.

Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico City

S. Ávila-Ríos, G. Reyes-Terán, Y. Caro-Vega, 2021, PloS one.

Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status.

D. Hom, Z. Toossi, J. Sierra-Madero, 1994, The Journal of infectious diseases.

Laparoscopic approach to fever of unknown origin

D. Velázquez-Fernández, M. Herrera, A. Ángeles-Ángeles, 2003, Surgical Endoscopy And Other Interventional Techniques.

Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico.

C. Beyrer, S. Rodríguez-Ramírez, J. Sierra-Madero, 2017, AIDS research and human retroviruses.

A Cross-Sectional Study of Prisoners in Mexico City Comparing Prevalence of Transmissible Infections and Chronic Diseases with That in the General Population

E. Serván-Mori, R. López‐Ridaura, S. Bautista-Arredondo, 2015, PLoS ONE.

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America

A. Mocroft, O. Kirk, A. Schultze, 2018, BMC Infectious Diseases.

Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.

J. Alberú, R. Correa-Rotter, L. Morales-Buenrostro, 2008, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Synchronous kinetics of CD4+ lymphocytes and viral load before the onset of oral candidosis and hairy leukoplakia in a cohort of Mexican HIV-infected patients.

L. Soto-Ramírez, V. Ramírez-Amador, G. Anaya-Saavedra, 2005, AIDS research and human retroviruses.

Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey.

C. Magis-Rodríguez, S. Ávila-Ríos, G. Reyes-Terán, 2016, The lancet. HIV.

Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort

P. Cahn, J. Pape, E. Gotuzzo, 2018, Journal of the International AIDS Society.

Comparative in vitro activity of cefoperazone and various combinations of cefoperazone/sulbactam.

J. Washington, J. Sierra-Madero, C. Knapp, 1990, Diagnostic microbiology and infectious disease.

Retention in Care, Mortality, Loss-to-Follow-Up, and Viral Suppression among Antiretroviral Treatment-Naïve and Experienced Persons Participating in a Nationally Representative HIV Pre-Treatment Drug Resistance Survey in Mexico

S. Ávila-Ríos, G. Reyes-Terán, Carlos Chivardi, 2021, Pathogens.

Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin America: burden and risk factors

T. Sterling, P. Cahn, E. Gotuzzo, 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Effectiveness of highly active antiretroviral therapy (HAART) among HIV-infected patients in Mexico.

C. del Rio, B. Crabtree-Ramírez, J. Sierra-Madero, 2010, AIDS research and human retroviruses.

Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network

P. Rebeiro, J. Pape, B. Shepherd, 2016, Journal of acquired immune deficiency syndromes.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor

D. Olvera-Posada, J. Sierra-Madero, R. Castillejos-Molina, 2014, Sexual medicine.

Monitoring of HIV treatment in seven countries in the WHO Region of the Americas

P. Cahn, J. Pape, E. Gotuzzo, 2015, Bulletin of the World Health Organization.

The HIV care continuum in Latin America: challenges and opportunities.

C. del Rio, P. Cahn, J. Sierra-Madero, 2015, The Lancet. Infectious diseases.

Clinical and virologic outcomes after changing first antiretroviral regimen at 7 sites in the Caribbean, Central, and South America Network (CCASAnet)

J. Pape, E. Gotuzzo, B. Grinsztejn, 2013 .

The Successful Application of a National Peer Advisory Committee for Physicians Who Provide Salvage Regimens to Heavily Antiretroviral-Experienced Patients in Mexican Human Immunodeficiency Virus Clinics

L. Soto-Ramírez, J. Calva, P. Aguilar-Salinas, 2014, Open forum infectious diseases.

Mediation of entry of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-A.

L. Guay, J. Sierra-Madero, E. Rich, 1997, American journal of respiratory cell and molecular biology.

Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1

Z. Toossi, R. Blinkhorn, J. Sierra-Madero, 1993, The Journal of experimental medicine.

Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America

J. Pape, B. Shepherd, B. Crabtree-Ramírez, 2020, PloS one.

Pyridostigmine in the treatment of adults with severe SARS-CoV-2 infection (PISCO): a randomised, double-blinded, phase 2/3, placebo-controlled trial

D. Manzur-Sandoval, S. Valdés-Ferrer, J. Calva, 2021 .

Safety and efficacy of Virend for topical treatment of genital and anal herpes simplex lesions in patients with AIDS.

E. Rozhon, R. Orozco‐Topete, E. Vázquez-Valls, 1997, Antiviral Research.

Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial

C. Katlama, D. Cooper, B. Grund, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Toxic pseudomembranous colitis in a patient with ulcerative colitis.

L. Uscanga, A. Gamboa-Domínguez, J. Sierra-Madero, 2000, Inflammatory bowel diseases.

Toxic pseudomembranous colitis in a patient with ulcerative colitis

L. Uscanga, A. Gamboa-Domínguez, J. Sierra-Madero, 2000 .

[Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].

L. Soto-Ramírez, H. Díliz, J. Alberú, 2002, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

The Population Impact of Late Presentation with Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America.

P. Rebeiro, J. Pape, V. Rouzier, 2020, American journal of epidemiology.

Implementation of PrEP in Latin America.

L. Guerrero-Torres, J. Sierra-Madero, 2022, The lancet. HIV.

Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico

C. Beyrer, Saifuddin Ahmed, J. Sierra-Madero, 2017, PloS one.

Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit.

C. del Rio, G. Ruiz-Palacios, L. Soto-Ramírez, 2007, Archives of medical research.

HIV and Noncommunicable Diseases (NCDs) in Latin America: A Call for an Integrated and Comprehensive Response

C. del Rio, B. Grinsztejn, B. Crabtree-Ramírez, 2014, Journal of acquired immune deficiency syndromes.

CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY.

D. Kershenobich-Stalnikowitz, G. Ruiz-Palacios, E. Rivero-Sigarroa, 2020, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study

H. Lopez-Gatell, G. Reyes-Terán, R. Perez-Padilla, 2021, Clinical Immunology.

Higher Veterans Aging Cohort Study (VACS) 2.0 Index Scores Predicts Functional Decline among Older Adults Living with HIV.

H. Amièva, B. Crabtree-Ramírez, J. Sierra-Madero, 2021, AIDS research and human retroviruses.

Impact of the immune reconstitution inflammatory syndrome (IRIS) on mortality and morbidity in HIV-infected patients in Mexico.

B. Crabtree-Ramírez, J. Sierra-Madero, A. Galindo-Fraga, 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Correlates of depressive symptoms among older adults living with HIV

H. Amièva, J. Sierra-Madero, Pablo F Belaunzarán-Zamudio, 2018, International journal of geriatric psychiatry.

Correlates of Prevalent Disability Among HIV-Infected Elderly Patients.

H. Amièva, B. Crabtree-Ramírez, J. Sierra-Madero, 2016, AIDS research and human retroviruses.

Gaps in the continuum of care in HIV-positive adults and the need for caution in those returning to care after loss to follow-up.

B. Crabtree-Ramírez, Y. Caro-Vega, J. Sierra-Madero, 2022, AIDS care.

Clinical Characteristics and Mortality of Health-Care Workers With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Mexico City

L. Guerrero-Torres, B. Crabtree-Ramírez, Y. Caro-Vega, 2020, Clinical Infectious Diseases.

Clinical Characteristics and Mortality of Healthcare Workers with SARS-CoV-2 infection in Mexico City

L. Guerrero-Torres, B. Crabtree-Ramírez, Y. Caro-Vega, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America

Richard D Moore, J. Willig, T. Sterling, 2016, Journal of the International AIDS Society.

Burden and severity of mpox in Mexico 6 months into the outbreak

G. Reyes-Terán, S. Valdés-Ferrer, J. Sierra-Madero, 2023, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Kluyvera mediastinitis following open-heart surgery: a case report

D. Longworth, J. Sierra-Madero, G. Hall, 1990, Journal of clinical microbiology.

Bilateral Forearm Transplantation in Mexico: 2-Year Outcomes

J. Ramos-Peek, A. Gamboa-Domínguez, J. Sierra-Madero, 2016, Transplantation.

Bilateral Proximal Forearm Transplantation: Case Report at 7 Years

C. Hernandez-Castillo, J. Dorantes-García, J. Sierra-Madero, 2019, Transplantation.

Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process

D. Richman, R. Rajasuriar, G. Behrens, 2021, HIV medicine.

Swine-origin influenza A (H1N1) and HIV. The CDC offers guidance for HIV-infected patients potentially exposed to swine flu.

C. del Rio, J. Sierra-Madero, 2009, Journal watch. AIDS clinical care.

Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: a growing challenge

B. Grinsztejn, B. Shepherd, B. Crabtree-Ramírez, 2018, Epidemiology and Infection.

Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America

J. Pape, E. Gotuzzo, B. Grinsztejn, 2018, Open forum infectious diseases.

Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study

P. Rebeiro, E. Gotuzzo, P. Luz, 2022, Lancet Regional Health. Americas.

Disseminaded coccidiodomycosis presentig as acute respiratory distress syndrome in a liver postrasplant recipient

J. Sierra-Madero, Alvaro López-Iñiguez, Darwin Lambraño-Castillo, 2021 .

Different Baseline Characteristics and Different Outcomes of HIV-Infected Patients Receiving HAART Through Clinical Trials Compared With Routine Care in Mexico

B. Crabtree-Ramírez, Y. Caro-Vega, J. Sierra-Madero, 2012, Journal of acquired immune deficiency syndromes.

Did Universal Access to ARVT in Mexico Impact Suboptimal Antiretroviral Prescriptions?

M. A. Colchero, S. Bautista-Arredondo, B. Crabtree-Ramírez, 2013, AIDS research and treatment.

III. THE ROLE OF THE RESEARCH ETHICS COMMITTEES IN THE REGULATION OF PHARMA-SPONSORED STUDIES.

C. Aguilar-Salinas, A. González-Duarte, J. Sierra-Madero, 2019, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Incomplete ART Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV-infection in Mexico.

R. Fuentes-García, B. Crabtree-Ramírez, Y. Caro-Vega, 2023, AIDS research and human retroviruses.

Temporal changes in ART initiation in adults with high CD4 counts in Latin America: a cohort study

P. Rebeiro, E. Gotuzzo, V. Veloso, 2019, Journal of the International AIDS Society.

Pyridostigmine in adults with severe SARS-CoV-2 infection: the PISCO trial

D. Manzur-Sandoval, S. Valdés-Ferrer, J. Calva, 2021, medRxiv.

Multiple sclerosis typical clinical and MRI findings in a patient with HIV infection

A. González-Duarte, J. Sierra-Madero, C. Ramírez, 2011, Journal of NeuroVirology.

Rapid scaling-up of access to antiretroviral therapy in Mexico: Is it better not to treat?

P. Cornejo, J. Sierra-Madero, P. Volkow, 2007, AIDS.

Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.

Tania B. Huedo-Medina, M. Hughes, P. Sax, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased risk of suicidal behaviour with use of efavirenz: results from the START trial

C. Katlama, D. Cooper, B. Grund, 2016 .

Opsoclonus-myoclonus-ataxia syndrome associated with central nervous system HIV-1 escape phenomenon.

L. Soto-Ramírez, J. Sierra-Madero, M. Hernandez-Flores, 2020, Revista de neurología (Ed. impresa).

The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico

V. Ramírez-Amador, G. Anaya-Saavedra, J. Sierra-Madero, 2003, Medicine.

Novel HLA class I associations with HIV-1 control in a unique genetically admixed population

P. Harrigan, S. Ávila-Ríos, G. Reyes-Terán, 2018, Scientific Reports.

ORIGINAL RESEARCH—ERECTILE DYSFUNCTION Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor

D. Olvera-Posada, J. Sierra-Madero, R. Castillejos-Molina, 2014 .

Predictors of laboratory-confirmed mpox in people with mpox-like illness.

S. Valdés-Ferrer, J. Sierra-Madero, J. Mosqueda-Gómez, 2023, Clinical Microbiology and Infection.

Burden and severity of mpox in Mexico 6 months into the outbreak

G. Reyes-Terán, S. Valdés-Ferrer, J. Sierra-Madero, 2023, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Necrotic lesion in an immunosuppressed patient.

J. Sierra-Madero, María Teresa Pérez-Gutiérrez, Alvaro López-Iñiguez, 2017, Enfermedades infecciosas y microbiologia clinica.

Mexico's fragmented health system as a barrier to HIV care.

C. Magis-Rodríguez, B. Crabtree-Ramírez, J. Sierra-Madero, 2019, The lancet. HIV.

Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey.

C. Magis-Rodríguez, S. Ávila-Ríos, G. Reyes-Terán, 2016, The lancet. HIV.